An interventional study of Virtual Visit in Heart Failure, Hypertension and Diabetes Mellitus, sponsored by Brigham and Women's Hospital. Terminated at 1 site in United States. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2021-09-22.
Sponsored by Brigham and Women's Hospital · Not applicable, Interventional, and Other
Clinicians slated for virtual visit rollout will be randomized (stratified by department) to either receive immediate virtual visit on-boarding (intervention arm) or delayed (3-months later) virtual visit on-boarding (control arm). The investigators plan to enroll no more than 200 clinicians.
Any clinician in a department selected by the Brigham Health Virtual Care team for access to virtual visits is eligible, unless s/he saw less than 20 patients monthly over the last 6 months.
The Brigham Health Virtual Care team will onboard all clinicians and provide virtual visit support as per their usual protocol. The primary study endpoint is third-available appointment, a well-adopted measure of access. Other secondary endpoints revolve around continuity, efficiency, utilization, safety, cost, and patient experience.
If enrolled in the intervention arm, the following steps will occur:
If enrolled in the control arm, the following steps will occur:
The investigators plan to follow patients of both clinician cohorts for a total of 6-months. The investigators will perform retrospective review of patient electronic health records and patients will receive a redcap survey (attached), an evaluation mechanism already employed by the Virtual Care team.
Again, aside from the initial randomization and retrospective data collection and analysis, all of the above would have occurred irrespective of this research protocol.
820 studies on the registry are indexed under Hyperlipidemias; 105 are open to participants now.
This study's enrollment of 77 is below the median of 88 across 691 interventional studies indexed under Hyperlipidemias.
Browse Hyperlipidemias studies →Brigham and Women's Hospital is the lead sponsor of 1,236 studies on the registry; 224 are open to participants now.
Of its 116 completed or terminated interventional studies of FDA-regulated products, 64 (55%) have results posted.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
If enrolled in the intervention arm, the following steps will occur: * The Brigham Health Virtual Care team will work with the clinician toward immediate on-boarding (software training, hardware setup, technical support) as per their usual process. * The clinician will schedule virtual visits as s/he and/or her/his department see fit. Virtual visits occur on an already-in-use Partners- and Brigham-approved video platform.
Other: Virtual Visit
If enrolled in the control arm, the following steps will occur: * Three months from the time of the follow-up email, the Brigham Health Virtual Care team will work with the clinician toward immediate on-boarding (software training, hardware setup, technical support) as per their usual process. * The clinician will schedule virtual visits as s/he and/or her/his department see fit. Virtual visits occur on an already-in-use Partners- and Brigham-approved video platform.
Clinicians will have a synchronous video visit with their patients.
Days until third available appointment
Number of days until the third available routine appointment, obtained at 12 o'clock each Friday (embargoed appointments not included). The mean of all of the weeks is a clinician's average number of days until the third available routine appointment.
Time frame: Through study completion, an average of 6 months
Days until first available appointment
Number of days until the next available routine appointment, obtained at 12 o'clock each Friday (embargoed appointments not included). The mean of all of the weeks is a clinician's average number of days until the next available routine appointment.
Time frame: Through study completion, an average of 6 months
Future capacity: percentage of open appointment slots
Percentage of appointment slots that are open and available for booking patients over the next four weeks, obtained at 12 o'clock each Friday (embargoed appointments not included). The mean of all of the weeks is a clinician's future capacity.
Time frame: Through study completion, an average of 6 months
Frequency of visits with the usual provider of care
Ratio of the number of visits to the most frequently seen provider to the total number of visits to all providers obtained each month. The mean of all of the months is a clinician's ratio.
Time frame: Through study completion, an average of 6 months
Continuity of care index
The number of visits to each individual physician divided by the total number of visits the patient had overall obtained each month. The mean of all of the months is the continuity of care index
Time frame: Through study completion, an average of 6 months
No show rate
Ratio of the number of no-show visits to total visit slots obtained each week. The mean of all of the weeks is a clinician's no show rate.
Time frame: Through study completion, an average of 6 months
Visit time
In-person: face time with patient per pertinent EHR fields, obtained each week. The mean of all of the weeks is a clinician's visit time. Virtual: enter virtual waiting room to video stops, obtained each week. The mean of all of the weeks is a clinician's visit time.
Time frame: Through study completion, an average of 6 months
Clinician volume per hour
Patients seen per hour, calculated at the end of the study.
Time frame: Through study completion, an average of 6 months
Clinician volume per day
Patients seen per day, all calculated at the end of the study.
Time frame: Through study completion, an average of 6 months
Clinician volume per month
Patients seen per month, all calculated at the end of the study.
Time frame: Through study completion, an average of 6 months
Clinician volume per 6 months
Patients seen per 6 months, all calculated at the end of the study.
Time frame: Through study completion, an average of 6 months
Slot utilization
Ratio of used slots to total slots, obtained each week. The mean of all of the weeks is a clinician's slot utilization.
Time frame: Through study completion, an average of 6 months
Number of primary care visits
Number of primary care visits
Time frame: Through study completion, an average of 6 months
Number of specialist visits
Number of specialist visits
Time frame: Through study completion, an average of 6 months
Number of emergency department visits
Number of emergency department visits
Time frame: Through study completion, an average of 6 months
Number of inpatient admissions
Number of inpatient admissions
Time frame: Through study completion, an average of 6 months
Number of imaging studies
Number of imaging studies ordered
Time frame: Through study completion, an average of 6 months
Number of labs ordered
Number of laboratory studies ordered
Time frame: Through study completion, an average of 6 months
Number of medications prescribed
Number of medications prescribed
Time frame: Through study completion, an average of 6 months
Patient Experience
Brigham Health Virtual Care team survey sent to participating patients
Time frame: Sent electronically within 1 week of the in-person or virtual visit
Revenue from virtual or in-person visit
Revenue garnered by an individual clinician for her/his clinical activity, calculated per hour and per 6 months (denominator: total clinical hours worked).
Time frame: Through study completion, an average of 6 months
Plan to share: No
This study is terminated, as verified in Sep 2021. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Brigham and Women's Hospital